Intel chip gear aims to detect disease

by Michael Johns, Project Manager | March 31, 2004

The chipmaker Intel and the Seattle-based research organization will construct a device, called a Raman Bioanalyzer System, that may be able, ideally, to detect chemical anomalies in individual cells and thereby be used to flag diseases in their early stages.

"The instrument beams lasers onto tiny medical samples, such as blood serum, to create images that reveal the chemical structure of molecules,"Andrew Berlin, lead researcher of Intel's Precision Biology program, said in a statement. "The goal is to determine if this technology, previously used to detect microscopic imperfections on silicon chips, can also detect subtle traces of disease."

To read more please click on the link below

You don’t have to invest heavily in CT technology to achieve your Coronary CTA goals

Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.

Intel chip aims to detect disease

This information is taken from an article by By Michael Kanellos, Staff Writer, CNET News.com

Submitted by Michael Johns, Staff Reporter, DOTmed.com.